Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation
Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and du...
Gespeichert in:
Veröffentlicht in: | Circulation Journal 2013, Vol.77(5), pp.1091-1096 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1096 |
---|---|
container_issue | 5 |
container_start_page | 1091 |
container_title | Circulation Journal |
container_volume | 77 |
creator | Latchamsetty, Rakesh Morady, Fred |
description | Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and duration and method of follow-up. Equally elusive is the proper definition of a successful ablation outcome. Should a “successful” ablation necessitate complete resolution of AF and AF symptoms documented by long-term monitoring, or does a more clinical approach evaluating for symptomatic improvement constitute a favorable outcome? Furthermore, at what point following an ablation should a recurrence be an acceptable, if not an expected, occurrence and should a significant decrease in AF burden warrant consideration as success? Our goal here will be to explore the current data evaluating outcomes for ablation of AF. We will examine electrophysiologic and other clinical endpoints, and hope to provide long-term expectations following ablation of paroxysmal and persistent AF. (Circ J 2013; 77: 1091–1096) |
doi_str_mv | 10.1253/circj.CJ-13-0298 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1346581628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1346581628</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-b4d43a90556eeb0e766d05f627757bc5e2e315b8d28fe579da3f03d30c530b4d3</originalsourceid><addsrcrecordid>eNpFkDFPwzAQhS0EoqWwM6GMLC5OHMfJWKIGqCqxlNlynEvrKo2L7Qrx70ma0i53p9P3nu4eQo8hmYYRoy9KW7Wd5gscUkyiLL1C45DGHMdpRK6Pc4KzNKYjdOfclnQIYdktGkWUxUnM6RjNl6Zd4xXYXfAKLdTau6AwTWN-dLsOcuk34MEGs7KRXps2MHUw81bLJih0aXUzrO_RTS0bBw-nPkFfxXyVv-Pl59tHPltixTLmcRlXMZXdDSwBKAnwJKkIq5OIc8ZLxSACGrIyraK0BsazStKa0IoSxSjpxHSCngffvTXfB3Be7LRT0F3Rgjk40T_M0jCJ0g4lA6qscc5CLfZW76T9FSERfXjiGJ7IF51K9OF1kqeT-6HcQXUW_KfVAcUAbJ2XazgD0nqtGjg5ci5YXy7OF2AjrYCW_gFJ7IRv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1346581628</pqid></control><display><type>article</type><title>Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Latchamsetty, Rakesh ; Morady, Fred</creator><creatorcontrib>Latchamsetty, Rakesh ; Morady, Fred</creatorcontrib><description>Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and duration and method of follow-up. Equally elusive is the proper definition of a successful ablation outcome. Should a “successful” ablation necessitate complete resolution of AF and AF symptoms documented by long-term monitoring, or does a more clinical approach evaluating for symptomatic improvement constitute a favorable outcome? Furthermore, at what point following an ablation should a recurrence be an acceptable, if not an expected, occurrence and should a significant decrease in AF burden warrant consideration as success? Our goal here will be to explore the current data evaluating outcomes for ablation of AF. We will examine electrophysiologic and other clinical endpoints, and hope to provide long-term expectations following ablation of paroxysmal and persistent AF. (Circ J 2013; 77: 1091–1096)</description><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.CJ-13-0298</identifier><identifier>PMID: 23546473</identifier><language>eng</language><publisher>Japan: The Japanese Circulation Society</publisher><subject>Ablation ; Atrial fibrillation ; Atrial Fibrillation - complications ; Atrial Fibrillation - mortality ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - surgery ; Catheter Ablation - adverse effects ; Catheter Ablation - mortality ; Humans ; Outcomes ; Recurrence ; Risk Factors ; Stroke - etiology ; Stroke - prevention & control ; Thromboembolism - etiology ; Thromboembolism - prevention & control ; Time Factors ; Treatment Outcome</subject><ispartof>Circulation Journal, 2013, Vol.77(5), pp.1091-1096</ispartof><rights>2013 THE JAPANESE CIRCULATION SOCIETY</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-b4d43a90556eeb0e766d05f627757bc5e2e315b8d28fe579da3f03d30c530b4d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23546473$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Latchamsetty, Rakesh</creatorcontrib><creatorcontrib>Morady, Fred</creatorcontrib><title>Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and duration and method of follow-up. Equally elusive is the proper definition of a successful ablation outcome. Should a “successful” ablation necessitate complete resolution of AF and AF symptoms documented by long-term monitoring, or does a more clinical approach evaluating for symptomatic improvement constitute a favorable outcome? Furthermore, at what point following an ablation should a recurrence be an acceptable, if not an expected, occurrence and should a significant decrease in AF burden warrant consideration as success? Our goal here will be to explore the current data evaluating outcomes for ablation of AF. We will examine electrophysiologic and other clinical endpoints, and hope to provide long-term expectations following ablation of paroxysmal and persistent AF. (Circ J 2013; 77: 1091–1096)</description><subject>Ablation</subject><subject>Atrial fibrillation</subject><subject>Atrial Fibrillation - complications</subject><subject>Atrial Fibrillation - mortality</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - surgery</subject><subject>Catheter Ablation - adverse effects</subject><subject>Catheter Ablation - mortality</subject><subject>Humans</subject><subject>Outcomes</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>Stroke - etiology</subject><subject>Stroke - prevention & control</subject><subject>Thromboembolism - etiology</subject><subject>Thromboembolism - prevention & control</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkDFPwzAQhS0EoqWwM6GMLC5OHMfJWKIGqCqxlNlynEvrKo2L7Qrx70ma0i53p9P3nu4eQo8hmYYRoy9KW7Wd5gscUkyiLL1C45DGHMdpRK6Pc4KzNKYjdOfclnQIYdktGkWUxUnM6RjNl6Zd4xXYXfAKLdTau6AwTWN-dLsOcuk34MEGs7KRXps2MHUw81bLJih0aXUzrO_RTS0bBw-nPkFfxXyVv-Pl59tHPltixTLmcRlXMZXdDSwBKAnwJKkIq5OIc8ZLxSACGrIyraK0BsazStKa0IoSxSjpxHSCngffvTXfB3Be7LRT0F3Rgjk40T_M0jCJ0g4lA6qscc5CLfZW76T9FSERfXjiGJ7IF51K9OF1kqeT-6HcQXUW_KfVAcUAbJ2XazgD0nqtGjg5ci5YXy7OF2AjrYCW_gFJ7IRv</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Latchamsetty, Rakesh</creator><creator>Morady, Fred</creator><general>The Japanese Circulation Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2013</creationdate><title>Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation</title><author>Latchamsetty, Rakesh ; Morady, Fred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-b4d43a90556eeb0e766d05f627757bc5e2e315b8d28fe579da3f03d30c530b4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Ablation</topic><topic>Atrial fibrillation</topic><topic>Atrial Fibrillation - complications</topic><topic>Atrial Fibrillation - mortality</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - surgery</topic><topic>Catheter Ablation - adverse effects</topic><topic>Catheter Ablation - mortality</topic><topic>Humans</topic><topic>Outcomes</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>Stroke - etiology</topic><topic>Stroke - prevention & control</topic><topic>Thromboembolism - etiology</topic><topic>Thromboembolism - prevention & control</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Latchamsetty, Rakesh</creatorcontrib><creatorcontrib>Morady, Fred</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Latchamsetty, Rakesh</au><au>Morady, Fred</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2013</date><risdate>2013</risdate><volume>77</volume><issue>5</issue><spage>1091</spage><epage>1096</epage><pages>1091-1096</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><abstract>Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and duration and method of follow-up. Equally elusive is the proper definition of a successful ablation outcome. Should a “successful” ablation necessitate complete resolution of AF and AF symptoms documented by long-term monitoring, or does a more clinical approach evaluating for symptomatic improvement constitute a favorable outcome? Furthermore, at what point following an ablation should a recurrence be an acceptable, if not an expected, occurrence and should a significant decrease in AF burden warrant consideration as success? Our goal here will be to explore the current data evaluating outcomes for ablation of AF. We will examine electrophysiologic and other clinical endpoints, and hope to provide long-term expectations following ablation of paroxysmal and persistent AF. (Circ J 2013; 77: 1091–1096)</abstract><cop>Japan</cop><pub>The Japanese Circulation Society</pub><pmid>23546473</pmid><doi>10.1253/circj.CJ-13-0298</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1346-9843 |
ispartof | Circulation Journal, 2013, Vol.77(5), pp.1091-1096 |
issn | 1346-9843 1347-4820 |
language | eng |
recordid | cdi_proquest_miscellaneous_1346581628 |
source | J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Ablation Atrial fibrillation Atrial Fibrillation - complications Atrial Fibrillation - mortality Atrial Fibrillation - physiopathology Atrial Fibrillation - surgery Catheter Ablation - adverse effects Catheter Ablation - mortality Humans Outcomes Recurrence Risk Factors Stroke - etiology Stroke - prevention & control Thromboembolism - etiology Thromboembolism - prevention & control Time Factors Treatment Outcome |
title | Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A32%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Benefits%20Following%20Catheter%20Ablation%20of%20Atrial%20Fibrillation&rft.jtitle=Circulation%20Journal&rft.au=Latchamsetty,%20Rakesh&rft.date=2013&rft.volume=77&rft.issue=5&rft.spage=1091&rft.epage=1096&rft.pages=1091-1096&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.CJ-13-0298&rft_dat=%3Cproquest_cross%3E1346581628%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1346581628&rft_id=info:pmid/23546473&rfr_iscdi=true |